Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

We are recommending PepsiCo and Target for investment in 2025 due to suppressed valuations and potential for growth amid ...

Five magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and ...

Walmart (NYSE: WMT) surged 71.9% in 2024, making it the second-best-performing component of the Dow Jones Industrial Average ...

CHINESE firms are attracting investors with increased dividends and buybacks, spurred by a policy push for corporate ...

The dividend yield on Chinese stocks has risen to around 3%, the highest since 2016, rewarding investors who have bravely ...

Chinese firms are attracting investors with increased dividends and buybacks, spurred by a policy push for corporate ...

Read here for an analysis of top dividend growth investments with strong historical performance to outperform benchmarks in the stock market.

Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

In Commercial Engines and Services, revenue climbed 19% to $7.65 billion, above the FactSet consensus of $7.32 billion, amid expanded shop visits, higher spare parts and prices. Orders soared 49.8% to ...

The two biggest questions for SCHD right now are 1) what’s caused it to underperform so badly, even within its category and 2) will those trends continue into 2025.

If you're looking for the best stocks to buy for the dividends, it may be time to look outside the U.S.